VSV-tumor selective replication and protein translation. - Wikidata - wikimedia - TriplyDB

VSV-tumor selective replication and protein translation.

VSV-tumor selective replication and protein translation.

http://www.wikidata.org/entity/Q34651274

about

Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer Early and Late Pathogenic Events of Newborn Mice Encephalitis Experimentally Induced by Itacaiunas and Curionópolis Bracorhabdoviruses Infection LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase Genome rearrangement affects RNA virus adaptability on prostate cancer cells.Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting.Anticancer oncolytic activity of respiratory syncytial virus.Explicit targeting of transformed cells by VSV in ovarian epithelial tumor-bearing Wv mouse models MicroRNAs and the regulation of vector tropism Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors.Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virus.Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates Endoplasmic reticulum chaperone gp96 is essential for infection with vesicular stomatitis virus.Interpreting whole genome and exome sequencing data of individual gastric cancer samples.Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity.Oncolytic viruses: From bench to bedside with a focus on safety.Therapeutics Based on microRNA: A New Approach for Liver Cancer Current status of gene therapy for brain tumors.VSV oncolytic virotherapy in the B16 model depends upon intact MyD88 signaling.hTERT extends the life of human fibroblasts without compromising type I interferon signaling.Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines.Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus.Vesicular stomatitis virus oncolytic treatment interferes with tumor-associated dendritic cell functions and abrogates tumor antigen presentation.RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses.Cell-type-specific growth restriction of vesicular stomatitis virus polR mutants is linked to defective viral polymerase function.Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1.A single amino acid change resulting in loss of fluorescence of eGFP in a viral fusion protein confers fitness and growth advantage to the recombinant vesicular stomatitis virus Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1 Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia Viruses - seeking and destroying the tumor program.Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation.HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy.Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis Viruses as anticancer drugs.Vesicular stomatitis virus variants selectively infect and kill human melanomas but not normal melanocytes

P2860

Q26774345-F9092209-AD15-4047-B4EC-8FF58CF9DADA Q26775038-4EFB6DA3-A54A-4CA9-9DD0-48CFF772587B Q26822694-69BB4E14-F94F-4384-960F-FA21944D0C0A Q27021839-15393B57-DAA4-4E17-8512-BC8E236A5FF2 Q27485432-927E9964-DD76-4EF6-BF54-BF68089C33C1 Q28118448-4AC88574-2324-45CF-81F7-FE768CAA616D Q28235509-A2821DF6-5F7A-4410-8CA5-CDFB6DD6F4BD Q30405759-D2E209B7-919C-4756-880A-9F53E06F79DA Q33579385-400D7C83-D478-4131-8F62-13F50317AB11 Q33614368-B26BF9E0-91EE-4275-97A2-862D48471CB0 Q33619829-C431A6F1-5DB3-4326-883D-D1DF206A2700 Q33620680-61E51C43-55E4-4293-B3B8-C67E5B889CE4 Q33713311-2104D6BC-B3A1-4528-971B-48642AE0243B Q33750535-229B88C0-5630-4012-BE0F-7581E2F6F795 Q33806399-2DF17911-CC2F-4096-8D0E-35BE18A6B509 Q33832148-04C65148-937B-41F6-A97B-317D6126B804 Q33832168-8427BD8E-3E27-4E22-9B4D-87335292CD07 Q33859437-C8D841FD-2D9B-42CC-B446-CB3D0E1ECAFB Q33882869-F7744BE1-58CB-4F0C-B167-DA67AE074EED Q33931640-E1035584-140F-43D9-A904-C254AE8B65FA Q34044071-AF2F15F3-FE3A-4195-9B60-2B33AB320693 Q34152847-0320AE77-7CF3-4594-AE5B-32AA46BC9D6A Q34318157-D4224911-02F5-408D-95E5-849E46BDFDAF Q34473352-F830E41A-1645-44A9-91C3-685742C04EDB Q34614831-64E82CBA-0DB9-4038-8836-0A657167E948 Q34648125-02F75EFB-A923-46AD-9ADA-6190C1FCA7FE Q34656877-63D9A413-B403-41F4-BFEC-67021953E073 Q35531563-708DE4BF-47B4-4721-B1FE-5B2920045452 Q35571345-367D6E64-A80C-42FD-9218-BD648C2915CB Q35635037-D4E2E3CE-55E6-487A-9334-6DE2854ADF47 Q36172960-000DE88E-BA2C-418A-9BFE-A96B8AF211DC Q36177154-09F991CF-EF1F-4B60-818B-01FE3F2D7045 Q36202610-CB34FF17-E0A1-4CEA-A985-3B2C892C3C0D Q36281149-4454DF5E-9E9A-46A3-BBFA-2C0C76F88884 Q36318145-2D8B129F-4249-4024-9FC0-FD8C1C858627 Q36673201-5F1C55E7-565D-4A5D-B306-7CA7A6D7ACBF Q36740297-6CE610DB-A050-4809-98C5-79AEBD267447 Q36845783-C84C8EFF-3060-44BD-B204-9C36CA45976C Q36850878-2E4EE664-8989-40D0-A94B-192D2C7F8F9E Q36911654-6AF994DA-FC35-4759-BB81-66481F82AAA3

P2860

VSV-tumor selective replication and protein translation.

http://www.wikidata.org/entity/Q34651274

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

VSV-tumor selective replication and protein translation.

@ast

VSV-tumor selective replication and protein translation.

@en

VSV-tumor selective replication and protein translation.

@nl

type

label

VSV-tumor selective replication and protein translation.

@ast

VSV-tumor selective replication and protein translation.

@en

VSV-tumor selective replication and protein translation.

@nl

prefLabel

VSV-tumor selective replication and protein translation.

@ast

VSV-tumor selective replication and protein translation.

@en

VSV-tumor selective replication and protein translation.

@nl

P1433

Q34651274-4FAAF685-0213-4A9F-B211-8D78F6332216

P1476

Q34651274-5B0997CB-42A1-43DF-85E9-5BBE00FDD2AB

P2093

Q34651274-75EF2176-6108-4B79-8CE3-E2B3C3EC5061

P2860

Q34651274-09194B30-6377-4875-857C-C013CA5D0E68

Q34651274-0D5DC580-4B37-42DF-99E5-165248EC966C

Q34651274-12B9D852-98CE-499F-9B40-DBE66973384C

Q34651274-3AAD7911-F57A-496F-8A69-D0EE2B6E59F1

Q34651274-45D8B58F-2095-456D-980A-B7B4CBEC22F1

Q34651274-48FDC43F-212D-4508-9DDB-BC955C80699B

Q34651274-63EE93EC-95E1-4E99-9A24-347E543F18D6

Q34651274-736A067D-3E6F-4643-A8D8-804C7EE46E45

Q34651274-877C192F-D1B1-4015-BC14-675FC6AF9BB1

Q34651274-8925A01E-5B81-4D84-99EC-12D208C79C0A

P2888

Q34651274-A71E602C-CA15-48E8-A5F7-FC4D13F7FA9A

P304

Q34651274-A9CEFE25-B107-4938-8806-53EA0136B410

P31

Q34651274-AC4E984E-68B3-432F-BCCA-DDF5425A5F65

P356

Q34651274-A8FE32E7-40F2-483F-BD2F-BC27DB196419

P407

Q34651274-255C0EED-1BB1-4C30-8AE1-6C407DCE488D

P433

Q34651274-153F27A6-6F2B-45FC-B435-A46790FF40DA

P478

Q34651274-D4650EBE-AD41-4A04-81FA-CBFDC564DAB1

P577

Q34651274-F32C8BB6-6834-4A3A-878F-7148AD40F816

P5875

Q34651274-D6B5ACAB-EB9E-4A4D-A7C0-2FA718CC2213

P6179

Q34651274-40B55FDB-55D7-40FE-BABF-C513A4EA95A2

P698

Q34651274-AE68CC23-DDBA-4F66-BDC2-665B3382E97F

P356

P1433

P1476

VSV-tumor selective replication and protein translation.

@en

P2093

Glen N Barber

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the mammalian initiation factor eIF2B complex as a GDP dissociation stimulator protein

mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties

Toll-like receptor signalling

How cells respond to interferons

Identification of interprotein interactions between the subunits of eukaryotic initiation factors eIF2 and eIF2B

Does the ribosome translate cancer?

Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1

The interferon regulatory factors and oncogenesis.

The molecular mechanics of eukaryotic translation.

Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein

P2888

P304

7710-7719

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1209042

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7468180

http://www.w3.org/2001/XMLSchema#string

P6179

1000620517

http://www.w3.org/2001/XMLSchema#string

P698

16299531

http://www.w3.org/2001/XMLSchema#string